News
MyChesCo on MSN38m
Ocugen Strengthens Leadership and Advisory Board as It Targets Three Biologics Filings in Three YearsMALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has expanded its Retina Scientific Advisory Board (SAB) and executive leadership team as the company accelerates toward filing three Biologics License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback